1. Home
  2. SGHT vs VTIX Comparison

SGHT vs VTIX Comparison

Compare SGHT & VTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$3.88

Market Cap

187.4M

Sector

Health Care

ML Signal

HOLD

VTIX

Virtuix Holdings Inc. Class A Common Stock

N/A

Current Price

$6.43

Market Cap

222.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
SGHT
VTIX
Founded
2011
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
187.4M
222.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SGHT
VTIX
Price
$3.88
$6.43
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$9.08
N/A
AVG Volume (30 Days)
235.0K
175.8K
Earning Date
05-07-2026
05-23-2026
Dividend Yield
N/A
N/A
EPS Growth
28.16
N/A
EPS
N/A
N/A
Revenue
$77,363,000.00
N/A
Revenue This Year
$11.67
N/A
Revenue Next Year
$10.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$4.39
52 Week High
$9.24
$9.00

Technical Indicators

Market Signals
Indicator
SGHT
VTIX
Relative Strength Index (RSI) 48.35 49.58
Support Level $3.29 $5.76
Resistance Level $4.29 $9.00
Average True Range (ATR) 0.19 0.70
MACD 0.09 -0.05
Stochastic Oscillator 69.10 48.27

Price Performance

Historical Comparison
SGHT
VTIX

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About VTIX Virtuix Holdings Inc. Class A Common Stock

Virtuix Holdings Inc develops technologies for immersive virtual environments, including both simulated and real-world applications. It develops virtual reality hardware and software, including the Omni Pro, an omni-directional treadmill designed to allow users to walk and run in multiple directions inside video games and other virtual worlds. The company operates at the intersection of gaming, fitness, and enterprise virtual reality. It has commercialized three products. The company operates in a single operating segment: the design, development, marketing, and sale of omni-directional treadmills, accessories, and related services to consumer and commercial customers. It derives revenue through a combination of hardware sales and recurring software and service income.

Share on Social Networks: